Literature DB >> 28484061

Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.

Lisa M Daum1, Elyse N Reamer1, Julie J Ruterbusch1, Joe Liu1, Margaret Holmes-Rovner1, Jinping Xu2.   

Abstract

BACKGROUND: Controversy surrounds treatment for localized prostate cancer (LPC).
OBJECTIVES: To assess men's localized prostate cancer (LPC) knowledge and its association with decision-making difficulty, satisfaction and regret.
METHODS: Population-based sample of 201 men (104 white, 97 black), ≤ 75 years with newly diagnosed LPC completed a self-administered survey.
RESULTS: Mean age was 61(±7.6) years; two-thirds had less than a Bachelor's degree. Mean LPC knowledge was low, 5.87 (±2.53, maximum score 11). More than a third of men who received surgery or radiation did not know about serious long-term treatment side effects. Fewer than half of the men correctly answered comparative side effect and survival benefit questions between surgery and radiation. Knowledge gaps were greatest among black men, men with lower education, single men. Tumor aggressiveness (i.e. PSA level, Gleason score) and treatment choice were not associated with knowledge. Knowledge was not associated with decisional satisfaction or regret. However, greater knowledge was associated with greater decision-making difficulty (P = .018).
CONCLUSIONS: Significant LPC knowledge gaps existed across groups, with greater knowledge gaps among black men. The association of decision-making difficulty with knowledge was independent of race. Better patient education is needed, but may not alleviate men's decision-making difficulty due to inherent scientific uncertainty. © Copyright 2017 by the American Board of Family Medicine.

Entities:  

Keywords:  Decision Making; Prostate Cancer

Mesh:

Year:  2017        PMID: 28484061     DOI: 10.3122/jabfm.2017.03.160298

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  7 in total

1.  Knowledge, Attitudes, and Behaviors of Imams on Prostate Cancer in Kahramanmaras, Turkey.

Authors:  Hüseyin Üçer; Hamit Sırrı Keten; Celal Kuş; Numan Güvenç; Oğuz Işık
Journal:  J Relig Health       Date:  2022-06-14

2.  Perceptions of partial gland ablation for prostate cancer among men on active surveillance: A qualitative study.

Authors:  Sonia S Hur; Michael Tzeng; Eliza Cricco-Lizza; Spyridon P Basourakos; Miko Yu; Jessica Ancker; Erika Abramson; Christopher Saigal; Ashley Ross; Jim Hu
Journal:  BMJ Surg Interv Health Technol       Date:  2021-06

3.  Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.

Authors:  Jinping Xu; Michael Goodman; James Janisse; Michael L Cher; Cathryn Hufford Bock
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

4.  Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with Prostate Cancer: Baseline Results from a Longitudinal Prospective Observational Study.

Authors:  Hayley Irusen; Henriette Burger; Pedro W Fernandez; Andre Van der Merwe; Tonya Esterhuizen; Danelo E du Plessis; Soraya Seedat
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

5.  Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country.

Authors:  N B Jalil; P Y Lee; M Z Nor Afiah; K L Abdullah; F N S Mohd Azizi; N N S Abdul Rassip; T A Ong; C J Ng; Y K Lee; A T Cheong; A H Razack; M Saad; A Alip; R Malek; M Sundram; S Omar; J R Sathiyananthan; P Kumar
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

6.  Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making.

Authors:  Nynikka R Palmer; Steven E Gregorich; Jennifer Livaudais-Toman; Jane Jih; Celia P Kaplan
Journal:  J Racial Ethn Health Disparities       Date:  2018-03-07

7.  Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.

Authors:  Jeffrey Belkora; June M Chan; Matthew R Cooperberg; John Neuhaus; Lauren Stupar; Tia Weinberg; Jeanette M Broering; Imelda Tenggara; Janet E Cowan; Stan Rosenfeld; Stacey A Kenfield; Erin L Van Blarigan; Jeffry P Simko; John Witte; Peter R Carroll
Journal:  Cancer Med       Date:  2019-11-12       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.